Can body creams be used during radiotherapy?

radiotherapy tolerance tests

SHORT VERSION

In general, body creams should not be used before the radiotherapy sessions because the skin must be as dry as possible before irradiation. 

Depending on the area to be treated, the application of a cream or ointment may not be recommended. Indeed, although some radiotherapy treatments (radiotherapy of breast, ENT, vulva or anal canal tumors) can cause skin reactions (redness, like a sunburn) during the treatment, most radiotherapy treatments do not induce any skin toxicity. This depends on the dose delivered to the skin. Therefore, skin reactions are more likely when the treated area is located immediately under the skin. However, these side effects disappear after the treatment end. On the other hand, radiotherapy for tumors located “deep down”, such as tumors in the abdomen or pelvis and lung cancer, give very few adverse skin reactions. Some systemic treatments (chemotherapy, targeted therapies) are likely to increase the risk of skin side effects and therefore, the oncologist may decide to stop them during the radiotherapy treatment.

Currently, there is no “miracle cream” to prevent and/or treat skin toxicities caused by radiotherapy. The most important thing is to follow the instructions given by the radiation oncologist and nurses. The application of cream before the sessions is contraindicated because the skin must be as dry as possible before irradiation. It is also recommended to wear loose-fitting clothing to limit friction with the skin. Patients who experience mild skin toxicities may use an emollient cream that contains hyaluronic acid. To patients with severe skin damage (intense redness, scaling) during treatment, the doctor or nurses will propose healing/reconstructive creams.

Radiotherapy

Notez cet post

FIRST TESTS TO PREDICT A PATIENT’S RADIOSENSITIVITY

NovaGray develops and commercializes the first radiotherapy tolerance tests for patients treated for breast or prostate cancer.

Performed before the start of radiotherapy with a simple blood draw, the tests assess the patients’ individual radiosensitivity and determine their risk of developing late complications after radiotherapy.

WHY DO A RADIOSENSITIVITY TEST?

Knowing a patient’s individual radiosensitivity is important information that can help:

  • Reassure the patient in preparation for radiotherapy
  • Guide physicians in choosing the most appropriate treatment plan
  • Adapt patient follow-up after radiotherapy

Team NovaGray

NovaGray develops radiotherapy tolerance tests for breast and prostate cancer patients. NovaGray's mission is to help personalize cancer treatment by assessing each patient's individual sensitivity before starting radiotherapy. NovaGray technology has been validated by multi-center prospective clinical trials. NovaGray tests are recommended by the French Society of Radiation Oncology (SFRO).